PAC-1 shows efficacy in dog trial

Chasing cancer with dogs — Treating canine cancers is helping researchers learn more about human forms of the disease. Thunder is ...
Read More

The Phase 1 clinical trial of PAC-1 in human cancer patients has begun!

See listing on, listen to the interview, watch a PBS documentary about comparative oncology including PAC-1, and watch the ...
Read More

Congratulations to Evi Llabani

Evi Llabani receives the inaugural C*Star Fellowship from the Cancer Center at Illinois ...
Read More

Vanquish Oncology, Inc. announces multimillion dollar investment to move PAC-1 to human clinical trials for cancer patients.

Cancer drug tested in pet dogs is now bound for human trials. University of Illinois chemistry professor Paul Hergenrother, left, ...
Read More